Ex-Bundestrainerin Nissinen für Weiterbeschäftigung Frehses t-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from t-online.de Daily Mail and Mail on Sunday newspapers.
The global supply of COVID-19 vaccine is "incredibly tight" and the COVAX dose-sharing facility is unlikely to procure much more supply in 2021 than doses already reserved, the Gavi vaccine alliance ceo Seth Berkley said on Thursday.
By Reuters Staff
1 Min Read
FILE PHOTO: The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, U.S., March 22, 2021. REUTERS/Rachel Wisniewski
(Reuters) -AstraZeneca Plc said on Wednesday that China’s health regulator expanded the use of Tagrisso, the British drugmaker’s lung cancer treatment, in patients with a type of lung cancer when diagnosed at an early stage.
China’s National Medical Products Administration (NMPA) approved Tagrisso as an adjuvant therapy for patients with early-stage lung cancer who have a mutation of the EGFR gene, AstraZeneca said.
The drug is now approved to treat early-stage lung cancer in more than a dozen countries, including, most recently, in the United States.
By Reuters Staff
2 Min Read
FILE PHOTO: A vial and sryinge are seen in front of a displayed Johnson&Johnson logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration
(Reuters) -Europe’s drug regulator said on Wednesday it planned to issue a recommendation on Johnson & Johnson’s COVID-19 vaccine next week, but that it continued to believe the benefits of the shot outweighed the risks of side effects.
The European Medicines Agency (EMA) is reviewing a small number of cases in the United States of very rare blood clotting disorders among people who had received the J&J vaccine.
By Reuters Staff
2 Min Read
FILE PHOTO: A vial and sryinge are seen in front of a displayed Johnson&Johnson logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration
(Reuters) -Europe’s drug regulator said on Wednesday it planned to issue a recommendation on Johnson & Johnson’s COVID-19 vaccine next week, but that it continued to believe the benefits of the shot outweighed the risks of side effects.
The European Medicines Agency (EMA) is reviewing a small number of cases in the United States of very rare blood clotting disorders among people who had received the J&J vaccine.